Business Lists and Databases Available for Marketing and Research - Direct Mailing Emailing Calling
NAICS Code 621111-17 - Pulmonary & Respiratory Diseases
Marketing Level - NAICS 8-DigitBusiness Lists and Databases Available for Marketing and Research
Business List Pricing Tiers
Quantity of Records | Price Per Record | Estimated Total (Max in Tier) |
---|---|---|
0 - 1,000 | $0.25 | Up to $250 |
1,001 - 2,500 | $0.20 | Up to $500 |
2,501 - 10,000 | $0.15 | Up to $1,500 |
10,001 - 25,000 | $0.12 | Up to $3,000 |
25,001 - 50,000 | $0.09 | Up to $4,500 |
50,000+ | Contact Us for a Custom Quote |
What's Included in Every Standard Data Package
- Company Name
- Contact Name (where available)
- Job Title (where available)
- Full Business & Mailing Address
- Business Phone Number
- Industry Codes (Primary and Secondary SIC & NAICS Codes)
- Sales Volume
- Employee Count
- Website (where available)
- Years in Business
- Location Type (HQ, Branch, Subsidiary)
- Modeled Credit Rating
- Public / Private Status
- Latitude / Longitude
- ...and more (Inquire)
Boost Your Data with Verified Email Leads
Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!
NAICS Code 621111-17 Description (8-Digit)
Parent Code - Official US Census
Tools
Tools commonly used in the Pulmonary & Respiratory Diseases industry for day-to-day tasks and operations.
- Spirometer
- Peak flow meter
- Oxygen concentrator
- Nebulizer
- Ventilator
- Bronchoscope
- Pulse oximeter
- Chest X-ray machine
- CT scanner
- MRI machine
Industry Examples of Pulmonary & Respiratory Diseases
Common products and services typical of NAICS Code 621111-17, illustrating the main business activities and contributions to the market.
- Asthma management
- COPD treatment
- Pneumonia diagnosis
- Lung cancer screening
- Tuberculosis management
- Pulmonary rehabilitation
- Sleep apnea treatment
- Cystic fibrosis management
- Pulmonary fibrosis diagnosis
- Bronchiectasis treatment
History
A concise historical narrative of NAICS Code 621111-17 covering global milestones and recent developments within the United States.
- The history of the Pulmonary & Respiratory Diseases industry dates back to ancient times, where the Greeks and Romans used various herbs and plants to treat respiratory ailments. In the 19th century, the discovery of anesthesia and the invention of the stethoscope revolutionized the diagnosis and treatment of respiratory diseases. The 20th century saw significant advancements in the industry, including the development of antibiotics, vaccines, and inhalers. In recent years, the industry has seen a surge in research and development, with new treatments and therapies being developed to combat respiratory diseases such as asthma, COPD, and lung cancer. In the United States, the industry has been heavily impacted by the COVID-19 pandemic, with a significant increase in demand for respiratory equipment and treatments.